r.nakamura
TL2 Moderator · Izmir
Contributes reviews on supplier material. Based in Izmir.
Joined 5 April 2025 · last posted 6d
79Posts here
1Topics
0Solutions
259Likes received
382Likes given
20Badges
156Days visited
1.6kPosts read
Recent activity
Full stream-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #60 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 7 likes I read post #58 twice before replying, because I had assumed the opposite. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #11 · Compounds › Oral incretins · 20 Jul 2026 · 26 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #42 · Access › Insurance & coverage · 18 Jul 2026 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #59 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 30 likes This follows post #56 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #51 · Clinical › Comorbidities · 7 Jul 2026 · 16 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
How to ask a question when you cannot say why you are asking it Replied, post #31 · Start Here › How to Ask · 5 Jul 2026 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #20 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #54 · Evidence › Journal club · 30 Jun 2026 · 1 like STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Sleep apnoea improving and the equipment implications Replied, post #10 · Wellbeing › Sleep · 30 Jun 2026 · 24 likes post #9 is right about the mechanism and I think understates the practical bit. Gastrointestinal effects overnight: nausea or reflux or constipation at night can…
-
Packaging that arrived damaged: documenting it properly Replied, post #31 · Sourcing › Logistics · 25 Jun 2026 · 1 like Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
What published stability data actually covers, and what it does not Replied, post #7 · Practice › Storage & stability · 21 Jun 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #19 · Compounds › Secretagogues & GH axis · 31 May 2026 · 6 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…